Browse by UCL people
Group by: Type | Date
Jump to: Article
Number of items: 4.
Article
Balendra, R;
Uphill, J;
Collinson, C;
Druyeh, R;
Adamson, G;
Hummerich, H;
Zerr, I;
... Mead, S; + view all
(2016)
Variants of PLCXD3 are not associated with variant or sporadic Creutzfeldt-Jakob disease in a large international study.
BMC Medical Genetics
, 17
, Article 28. 10.1186/s12881-016-0278-2.
|
Mead, S;
Burnell, M;
Lowe, J;
Thompson, A;
Lukic, A;
Porter, MC;
Carswell, C;
... Collinge, J; + view all
(2016)
Clinical Trial Simulations Based on Genetic Stratification and the Natural History of a Functional Outcome Measure in Creutzfeldt-Jakob Disease.
JAMA Neurology
, 73
(4)
pp. 447-455.
10.1001/jamaneurol.2015.4885.
|
Rohrer, JD;
Woollacott, IOC;
Dick, KM;
Brotherhood, E;
Gordon, E;
Fellows, A;
Toombs, J;
... Zetterberg, H; + view all
(2016)
Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia.
NEUROLOGY
, 87
(13)
pp. 1329-1336.
10.1212/WNL.0000000000003154.
|
Rudge, P;
Jaunmuktane, Z;
Adlard, P;
Bjurstrom, N;
Caine, D;
Lowe, J;
Norsworthy, P;
... Collinge, J; + view all
(2015)
Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years.
Brain
, 138
(Pt 11)
pp. 3386-3399.
10.1093/brain/awv235.
|